Comparative PK [Study Per­for­mance]

posted by PVRC – India, 2021-05-10 18:12 (41 d 15:20 ago) – Posting: # 22338
Views: 564

Hi all,

For one of the product, the agency recommend to demonstrate comparative PK in the absence of bioequivalence. The question is that whether all bioequivalence criteria (like 80-125%, group effect etc.,) are still applicable to demonstrate comparative PK.

Thanks in advance....

Complete thread:

 Admin contact
21,530 posts in 4,499 threads, 1,524 registered users;
online 12 (0 registered, 12 guests [including 3 identified bots]).
Forum time: Monday 09:33 CEST (Europe/Vienna)

Young man, in mathematics you don’t understand things.
You just get used to them.    John von Neumann

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz